aprevo® Digital Segmentation

Carlsmed, Inc. · K231955 · 2023-11-03

aprevo® Digital Segmentation is an AI-enabled medical device from Carlsmed, Inc., listed by FDA (510(k), K231955) with a decision date of 2023-11-03. Review panel: Radiology.

FDA submission numberK231955
Pathway510(k)
CompanyCarlsmed, Inc.
Review panel (specialty)Radiology
FDA decision date2023-11-03
DecisionSubstantially Equivalent
Product codeQIH
ClassificationAutomated Radiological Image Processing Software
Device class2
Regulation number892.2050
Review time (calendar days)123
Applicant countryUS

Official FDA database record · FDA AI-enabled device list

All Radiology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.